These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2315188)

  • 1. The patient with testicular cancer: nursing management of chemotherapy.
    Higgs DJ
    Oncol Nurs Forum; 1990; 17(2):243-9. PubMed ID: 2315188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of nausea and vomiting in children: nursing assessment and intervention.
    Hockenberry-Eaton M; Benner A
    Oncol Nurs Forum; 1990; 17(4):575-84. PubMed ID: 2204886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relieving nausea and vomiting in patients with cancer: a treatment algorithm.
    Johnson MH; Moroney CE; Gay CF
    Oncol Nurs Forum; 1997; 24(1):51-7. PubMed ID: 9007907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. History of testicular cancer chemotherapy: maximizing efficacy, minimizing toxicity.
    Sweeney C
    Semin Urol Oncol; 2001 Aug; 19(3):170-9. PubMed ID: 11561984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide.
    Shih V; Wan HS; Chan A
    Ann Pharmacother; 2009 Mar; 43(3):444-52. PubMed ID: 19193584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing chemotherapy-related nausea and vomiting: the state of the art.
    Wickham R
    Oncol Nurs Forum; 1989; 16(4):563-74. PubMed ID: 2666957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myths of antiemetic administration.
    Peters CA
    Cancer Nurs; 1989 Apr; 12(2):102-6. PubMed ID: 2713833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and antiemetic management of chemotherapy-induced nausea and vomiting.
    Goodman M
    Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):20-32. PubMed ID: 9282378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
    Hamadani M; Chaudhary L; Awan FT; Khan JK; Kojouri K; Ozer H; Tfayli A
    J Oncol Pharm Pract; 2007 Jun; 13(2):69-75. PubMed ID: 17873106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing the multiple causes of nausea and vomiting in the patient with cancer.
    Fessele KS
    Oncol Nurs Forum; 1996 Oct; 23(9):1409-15; quiz 1416-7. PubMed ID: 8899757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nurses' perceptions of antiemetic effectiveness.
    Rhodes VA; McDaniel RW; Simms SG; Johnson M
    Oncol Nurs Forum; 1995 Sep; 22(8):1243-52. PubMed ID: 8532549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Patient lack of knowledge about nausea in chemotherapy: becoming experts in their disease].
    Seeling S
    Pflege Z; 2005 Feb; 58(2):104-6. PubMed ID: 15754509
    [No Abstract]   [Full Text] [Related]  

  • 13. Cisplatin based chemotherapy in testicular cancer patients: long term platinum excretion and clinical effects.
    Hohnloser JH; Schierl R; Hasford B; Emmerich B
    Eur J Med Res; 1996 Sep; 1(11):509-14. PubMed ID: 9438151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation and treatment of testicular cancer.
    Hesketh PJ
    Hosp Pract (Off Ed); 1987 Sep; 22(9A):87-90, 93-102. PubMed ID: 2484998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the management of testicular cancer.
    Balk C; Witjes JA
    Expert Rev Anticancer Ther; 2004 Aug; 4(4):669-77. PubMed ID: 15270670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of Navoban for managing nausea and vomiting during the aggressive chemotherapy of malignant neoplasms].
    Seliuzhitskiĭ IV; Eliseev SN
    Voen Med Zh; 1993 Oct; (10):35-6. PubMed ID: 8303850
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
    Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the optimal management of chemotherapy-induced nausea and vomiting: a consensus.
    Osoba D; Warr DG; Fitch MI; Nakashima L; Warren B
    Can J Oncol; 1995 Sep; 5(3):381-400. PubMed ID: 8853513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of testicular and second cancer].
    Kawai K; Akaza H
    Gan To Kagaku Ryoho; 1999 Nov; 26(13):2021-8. PubMed ID: 10584566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug insight: New antiemetics in the management of chemotherapy-induced nausea and vomiting.
    Oo TH; Hesketh PJ
    Nat Clin Pract Oncol; 2005 Apr; 2(4):196-201. PubMed ID: 16264934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.